International Conference on Pharmaceutical Waste Control and Public Health
ICPWCPH
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the development and implementation of innovative strategies for managing pharmaceutical waste. Emphasis will be placed on case studies that demonstrate effective waste minimization and resource recovery techniques.
SDG 12
SDG 3
This session will explore the current regulatory landscape surrounding pharmaceutical waste management and its implications for public health. Discussions will include the evaluation of existing policy frameworks and recommendations for future improvements.
SDG 16
SDG 17
This track examines the role of environmental monitoring in ensuring the safety and efficacy of pharmaceutical waste disposal practices. Participants will discuss the development of safety protocols that protect public health and the environment.
SDG 3
SDG 6
This session will delve into lifecycle assessment methodologies as tools for evaluating the environmental impact of pharmaceutical products. The focus will be on identifying opportunities for reducing waste throughout the product lifecycle.
SDG 12
SDG 13
This track will highlight circular economy principles as they relate to pharmaceutical waste management. Participants will explore innovative approaches to resource efficiency and waste reduction within urban settings.
SDG 12
SDG 11
This session will address the challenges associated with hazardous materials in pharmaceutical waste. Emphasis will be placed on risk assessment methodologies that inform safe handling and disposal practices.
SDG 3
SDG 12
This track will focus on the importance of community engagement in the development of effective pharmaceutical waste management strategies. Discussions will include best practices for fostering public awareness and participation.
SDG 11
SDG 17
This session will explore the latest advancements in treatment technologies for pharmaceutical waste. Participants will discuss the efficacy and sustainability of various treatment methods in mitigating environmental impacts.
SDG 12
SDG 9
This track will investigate the use of sustainability metrics to assess the effectiveness of pharmaceutical waste management practices. The focus will be on developing indicators that support continuous improvement in waste reduction efforts.
SDG 12
SDG 9
This session will examine the intersection of urban waste management and public health, particularly in relation to pharmaceutical waste. Participants will discuss strategies for mitigating health risks associated with improper waste disposal.
SDG 3
SDG 11
This track will focus on the principles of cleaner production as a means to enhance resource efficiency in the pharmaceutical sector. Discussions will include innovative practices that minimize waste generation while maintaining product quality.
SDG 12
SDG 9